Wo Wu Biological: The supplementary application for clinical trials of swine grass pollen prick fluid medicine has been approved.

Iwu Biopharmaceuticals announced that the company recently obtained the "Notice of Approval for Supplementary Application for Drug Clinical Trials" downloaded from the official website of the National Medical Products Administration. The supplementary application for the clinical trial of "Pigweed Pollen Subcutaneous Injection" submitted by the company has been approved. The approved content is as follows: approval to increase the total allergen activity to 3500 DU/ml, with a bottle containing 2 ml of formulation.